<?xml version="1.0" encoding="UTF-8"?>
<p>Management of an infected pregnant women is essentially conditioned by maternal symptomatology. Women with little or no symptoms do not require routine treatment or in‐patient care and simply need to be monitored for up to 15 days for evidence of respiratory deterioration. In the absence of validated specific treatment, the primary approach to therapy is mainly symptomatic and delivery is considered in the event of critical respiratory distress in order to maximise oxygenation and lung capacity.
 <xref rid="bjo16270-bib-0003" ref-type="ref">
  <sup>3</sup>
 </xref>, 
 <xref rid="bjo16270-bib-0004" ref-type="ref">
  <sup>4</sup>
 </xref>, 
 <xref rid="bjo16270-bib-0005" ref-type="ref">
  <sup>5</sup>
 </xref> However, it has been reported that women with respiratory signs may be given antiviral treatment to improve their clinical condition.
 <xref rid="bjo16270-bib-0003" ref-type="ref">
  <sup>3</sup>
 </xref>, 
 <xref rid="bjo16270-bib-0005" ref-type="ref">
  <sup>5</sup>
 </xref>
</p>
